Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Serum Infliximab Levels in Severe Ulcerative Colitis

NCT01971814 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT01971814
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01971814 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Serum Infliximab Levels in Severe Ulcerative Colitis
Lead sponsor
University of California, San Francisco
Phase
Phase 1
Overall status
Completed
Start date
November 30, 2013
Completion date
January 31, 2015
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

inflammatory bowel disease, ulcerative colitis (uc)